Загрузка видео...

Не удалось загрузить видео

На главную

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that...

newstart_2024's profile picture

Camus

454,496 subscribers

421,812 просмотров • 9 месяцев назад •via X (Twitter)

Здоровье и велнесНаука и технологииНовости и политика
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?
5:12

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,060 просмотров • 7 месяцев назад

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.
5:53

A Medical Paradigm Built on Warfare is Failing Cancer Patients. Here’s the Breakthrough They Are Blocking. Dr. Patrick Soon-Shiong reveals a hard truth: our cancer treatment roots are in mustard gas & nuclear weapons—a system of "short-term survival scarred by fear, power, and control." He believed groundbreaking science would be embraced. He was wrong. The discovery? Your body has the ultimate weapon: the Natural Killer (NK) cell. We can now activate it with a simple protein (IL-15), creating a universal key to attack ALL cancer types. The FDA’s fatal flaw? Bureaucratic inertia & regulatory capture. They approve drugs for anemia (Epogen) or low neutrophils (Neupogen) regardless of tumor type. It's logical: you don't ask why you need a blood transfusion. Yet, when patients have low NK & T cells (lymphopenia)—a $20 test reveals this—the FDA refuses to approve IL-15 as the universal solution. It's like denying a transfusion for catastrophic blood loss. The proof is there: - ✅ Bladder cancer patients alive & cancer-free for 10+ years. - ✅ Data for pancreatic, lung, & head/neck cancers. The response? "Refused to file." They demand a randomized trial for every single cancer type—a process requiring "three lifetimes" while patients die. This isn't just about cancer. The immune system is the key to longevity. The world's oldest person, 117, had hyper-active NK cells. We have a simple, subcutaneous shot that can save lives now. The system, prioritizing money & consensus over people, is standing in the way. It's time for a revolution in medicine. The power to heal is already within us.

Camus

71,957 просмотров • 9 месяцев назад

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.
3:35

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.

Camus

55,260 просмотров • 8 месяцев назад

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.
5:44

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 просмотров • 9 месяцев назад

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.
5:40

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Dr. Pat Soon-Shiong

43,436 просмотров • 10 месяцев назад

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?
3:46

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,118 просмотров • 1 год назад

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.
2:58

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.

Camus

150,903 просмотров • 9 месяцев назад

Dr. Patrick Soon-Shiong just dropped a revolutionary revelation on Megyn Kelly: Your body already has the key to defeating cancer, infections, and even aging itself. The Hidden Power of Natural Killer (NK) Cells For 450 million years, a God-given cell—the Natural Killer Cell—has been silently protecting us. Discovered only in the 1970s, this cell is the body’s first responder, designed to destroy cancer, viruses (like COVID), bacteria, and sepsis. Yet, until now, no one knew how to fully activate it. BioShield: The Game-Changer Dr. Soon-Shiong’s 30-year breakthrough? A single subcutaneous jab that supercharges NK & T cells by leveraging Interleukin-15 (IL-15)—a protein your body already produces. But here’s the kicker: BioShield makes it last 7-14 days instead of seconds. PROVEN RESULTS - Bladder cancer patients treated in 2015 are STILL ALIVE, disease-free, with their bladders intact. - Lynch Syndrome trial (1 in 280 Americans) just completed—100% enrollment—testing BioShield as a preventative against cancer. The Silent Killer: Lymphopenia (Low ALC) Your Absolute Lymphocyte Count (ALC)—hidden in routine blood tests—could predict your survival. Below 1,000? Your risk of cancer, infection, and early death skyrockets. Yet, 99% of doctors ignore it… because until now, there was no treatment. Paradigm Shift: Treat the HOST, Not the Disease Cancer isn’t the root problem—it’s a symptom of a collapsed immune system. BioShield doesn’t just fight disease; it rebuilds your biological armor. The Future? Longevity. As we age, NK & T cells decline. BioShield could be the key to slowing immune collapse—potentially extending healthspan and lifespan. Dr. Soon-Shiong’s Challenge: Will the FDA recognize this paradigm-changing science in time? This isn’t just medicine. It’s a MIRACLE hiding in plain sight.
8:02

Dr. Patrick Soon-Shiong just dropped a revolutionary revelation on Megyn Kelly: Your body already has the key to defeating cancer, infections, and even aging itself. The Hidden Power of Natural Killer (NK) Cells For 450 million years, a God-given cell—the Natural Killer Cell—has been silently protecting us. Discovered only in the 1970s, this cell is the body’s first responder, designed to destroy cancer, viruses (like COVID), bacteria, and sepsis. Yet, until now, no one knew how to fully activate it. BioShield: The Game-Changer Dr. Soon-Shiong’s 30-year breakthrough? A single subcutaneous jab that supercharges NK & T cells by leveraging Interleukin-15 (IL-15)—a protein your body already produces. But here’s the kicker: BioShield makes it last 7-14 days instead of seconds. PROVEN RESULTS - Bladder cancer patients treated in 2015 are STILL ALIVE, disease-free, with their bladders intact. - Lynch Syndrome trial (1 in 280 Americans) just completed—100% enrollment—testing BioShield as a preventative against cancer. The Silent Killer: Lymphopenia (Low ALC) Your Absolute Lymphocyte Count (ALC)—hidden in routine blood tests—could predict your survival. Below 1,000? Your risk of cancer, infection, and early death skyrockets. Yet, 99% of doctors ignore it… because until now, there was no treatment. Paradigm Shift: Treat the HOST, Not the Disease Cancer isn’t the root problem—it’s a symptom of a collapsed immune system. BioShield doesn’t just fight disease; it rebuilds your biological armor. The Future? Longevity. As we age, NK & T cells decline. BioShield could be the key to slowing immune collapse—potentially extending healthspan and lifespan. Dr. Soon-Shiong’s Challenge: Will the FDA recognize this paradigm-changing science in time? This isn’t just medicine. It’s a MIRACLE hiding in plain sight.

Camus

224,784 просмотров • 1 год назад

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”
3:25

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”

Humanspective

16,695 просмотров • 1 месяц назад

Your body is already armed with a 460-million-year-old superpower that can hunt and destroy cancer cells on its own. Dr. Patrick Soon-Shiong — the billionaire surgeon who invented the blockbuster drug Abraxane — just explained in 4 jaw-dropping minutes how Natural Killer (NK) cells are the original immune defense every one of us carries… and how modern medicine has unintentionally been holding them back for decades. In this interview he reveals: - NK cells: the ancient protectors discovered in the 1970s that fight cancer, viruses, and trauma - The FDA-approved 2024 therapy that finally “turns on” your own NK cells like flipping a switch - Real-world patients with advanced bladder cancer now cancer-free for over 10 years - Why the same platform is showing massive promise against long COVID, HIV, sepsis, and many cancers This isn’t hype. It’s 30+ years of peer-reviewed science finally reaching patients. Watch the full 4:04 clip and then tell me in the comments: When you realized your immune system already has a built-in cancer-killing army that’s been waiting 460 million years… what went through your mind first? Hope? Shock? Gratitude? Let’s have an uplifting, respectful conversation about the future of medicine. Everyone is welcome. Drop your reaction below — I read every single one
4:04

Your body is already armed with a 460-million-year-old superpower that can hunt and destroy cancer cells on its own. Dr. Patrick Soon-Shiong — the billionaire surgeon who invented the blockbuster drug Abraxane — just explained in 4 jaw-dropping minutes how Natural Killer (NK) cells are the original immune defense every one of us carries… and how modern medicine has unintentionally been holding them back for decades. In this interview he reveals: - NK cells: the ancient protectors discovered in the 1970s that fight cancer, viruses, and trauma - The FDA-approved 2024 therapy that finally “turns on” your own NK cells like flipping a switch - Real-world patients with advanced bladder cancer now cancer-free for over 10 years - Why the same platform is showing massive promise against long COVID, HIV, sepsis, and many cancers This isn’t hype. It’s 30+ years of peer-reviewed science finally reaching patients. Watch the full 4:04 clip and then tell me in the comments: When you realized your immune system already has a built-in cancer-killing army that’s been waiting 460 million years… what went through your mind first? Hope? Shock? Gratitude? Let’s have an uplifting, respectful conversation about the future of medicine. Everyone is welcome. Drop your reaction below — I read every single one

Camus

122,420 просмотров • 7 месяцев назад

The NIH were sitting on a cancer breakthrough for 10 years, but did nothing with it. In a NEW report, we find out instead of helping this treatment without the toxicity of Chemo and radiation, the FDA just blocked it, choosing to give priority authorisation to Chemotherapy instead. IL-15 stimulates the bodies own natural cancer fighting capabilities, by up regulating the immune systems NK cells. Dr. Patrick Soon-Shiong explains how IL-15 was designated by the NIH as the most important molecule to fight cancer, but they couldn't make it work. "The NIH tried to develop this for 10 years." "The NIH and NCI designated this IL15 as the most important molecule to cure cancer, and they failed to develop it, because they couldn't make it last long [or] figure out how to actually just target directly the NK cells. We did that". Just months ago, 2 senior scientists in the FDA said “we don’t care” when Patrick Soon-Shiong approached them and urged for a priority approval process.
1:15

The NIH were sitting on a cancer breakthrough for 10 years, but did nothing with it. In a NEW report, we find out instead of helping this treatment without the toxicity of Chemo and radiation, the FDA just blocked it, choosing to give priority authorisation to Chemotherapy instead. IL-15 stimulates the bodies own natural cancer fighting capabilities, by up regulating the immune systems NK cells. Dr. Patrick Soon-Shiong explains how IL-15 was designated by the NIH as the most important molecule to fight cancer, but they couldn't make it work. "The NIH tried to develop this for 10 years." "The NIH and NCI designated this IL15 as the most important molecule to cure cancer, and they failed to develop it, because they couldn't make it last long [or] figure out how to actually just target directly the NK cells. We did that". Just months ago, 2 senior scientists in the FDA said “we don’t care” when Patrick Soon-Shiong approached them and urged for a priority approval process.

Humanspective

116,943 просмотров • 9 месяцев назад

The system is rigged against the immune system, destroying the very cells you need to fight cancer. "We've been doing it wrong". Patrick Soon-Shiong says Chemotherapy and Radiation "Wipe out" the only cells that matter for protecting your body against cancer. "Antkiva" (AKA Bioshield) is an IL-15 based treatment that the NIH designated as the most important molecule to fight cancer, and tried to develop it for 10 years but did nothing with it. They prioritised chemotherapy as standard of care.
0:29

The system is rigged against the immune system, destroying the very cells you need to fight cancer. "We've been doing it wrong". Patrick Soon-Shiong says Chemotherapy and Radiation "Wipe out" the only cells that matter for protecting your body against cancer. "Antkiva" (AKA Bioshield) is an IL-15 based treatment that the NIH designated as the most important molecule to fight cancer, and tried to develop it for 10 years but did nothing with it. They prioritised chemotherapy as standard of care.

Humanspective

77,482 просмотров • 7 месяцев назад

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.
6:39

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.

Camus

94,391 просмотров • 1 год назад

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.
3:48

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.

Camus

127,084 просмотров • 11 месяцев назад

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.
2:44

A Cancer Revolution Hidden in Plain Sight For 30 years, Dr. Patrick Soon-Shiong has pursued a radical truth—one that could rewrite how we treat cancer. And it’s been inside us all along. The Secret Weapon? Natural Killer (NK) Cells. These microscopic warriors evolved 450 million years ago to protect mammals. Watch this real footage—not animation—of an NK cell devouring a cancer cell. Then, the T-cell joins the fight. Together, they’re our body’s elite defense. The Paradigm Shift: What if cancer isn’t the root disease—but a symptom? A sign of immune collapse as we age or face infections? For decades, medicine has attacked cancer with tools that weaken immunity (chemotherapy, radiation, steroids). But what if we rebuild the immune system instead? The Proof: An FDA-approved therapy (already used for bladder cancer) proliferates NK cells, safely tested in 8,000 doses. This isn’t sci-fi—it’s science. The Mission: Educate the world. Challenge doctors, regulators, and patients to rethink cancer treatment. Because the cure may not come from a lab—but from harnessing what’s already within us. The Future of Medicine Starts Now.

Camus

49,252 просмотров • 11 месяцев назад

🔥 CANCER SCAM EXPOSED: Dr. Patrick Soon-Shiong Drops Bombshell — “Chemo Destroys the Very Cells That Could Save You” [VIDEO] 🔥 Exposed: Chemotherapy and radiation destroy your body’s natural killer cells — the immune warriors that could cure cancer. Dr. Patrick Soon-Shiong reveals “Bio-Shield Therapy,” a single injection keeping patients cancer-free for 10+ years. Biden’s FDA blocked it. Big Pharma tried to bury it. The future of medicine is here. 🔥 THE CANCER SCAM EXPOSED 👉 FULL STORY HERE: 📢 Join our Telegram channel: 🌐 Real stories. True journalism. Together, we make an impact:
2:58

🔥 CANCER SCAM EXPOSED: Dr. Patrick Soon-Shiong Drops Bombshell — “Chemo Destroys the Very Cells That Could Save You” [VIDEO] 🔥 Exposed: Chemotherapy and radiation destroy your body’s natural killer cells — the immune warriors that could cure cancer. Dr. Patrick Soon-Shiong reveals “Bio-Shield Therapy,” a single injection keeping patients cancer-free for 10+ years. Biden’s FDA blocked it. Big Pharma tried to bury it. The future of medicine is here. 🔥 THE CANCER SCAM EXPOSED 👉 FULL STORY HERE: 📢 Join our Telegram channel: 🌐 Real stories. True journalism. Together, we make an impact:

Medeea Greere

45,315 просмотров • 3 месяцев назад

Dr. Patrick Soon-Shiong challenges the core of cancer treatment: Are we fighting cancer incorrectly? In a compelling interview, he explains how lymphocytes—Natural Killer cells and T-cells—are the body’s critical defenders, essential for defeating cancer, infections, and sepsis. Yet, modern medicine has been undermining them. Lymphocytes are the body’s elite immune cells. Natural Killer cells and T-cells are uniquely equipped to destroy cancer cells and are vital for combating life-threatening infections and sepsis. Dr. Soon-Shiong describes them as the foundation for long life and survival. But there’s a problem. Conventional cancer treatments—chemotherapy, radiation, and steroids—destroy these lymphocytes, causing lymphopenia, a depletion akin to anemia but for the immune system. For decades, medicine has inadvertently targeted the very cells needed to win the war against cancer. A breakthrough molecule, IL-15, changes everything. This protein, produced naturally in the body, acts as a master switch to activate and proliferate lymphocytes, enabling them to eradicate cancer and infections. For the first time, medicine can harness this mechanism through BioShield. BioShield leverages IL-15 to empower lymphocytes, marking a revolutionary shift in treatment. Unlike chemotherapy, which Dr. Soon-Shiong likens to a nuclear bomb that devastates the body, IL-15 strengthens the immune system to fight smarter. Why have traditional treatments fallen short? Chemotherapy and radiation may shrink tumors, achieving what’s called a response, but at a steep cost. They deplete lymphocytes, weaken immunity, and allow resistant cancer cells to hide and later return as metastases. Dr. Soon-Shiong raises a provocative question: Have treatments induced incurability? The focus on response rates and progression-free survival, standard metrics for drug approval, misses the true goal: overall survival with high quality of life. Current therapies, often dosed at the maximum tolerated level, prioritize short-term wins over long-term health. Dr. Soon-Shiong critiques this approach, suggesting that medicine has been winning battles but losing wars. By destroying lymphocytes, treatments may shrink tumors temporarily but leave patients vulnerable to relapse. The regulatory system, he argues, has incentivized flawed endpoints. BioShield’s IL-15 therapy offers hope, activating the body’s natural defenses without obliterating them. This could redefine cancer care, prioritizing immune strength and long-term survival over transient tumor shrinkage. Dr. Soon-Shiong’s vision challenges 50 years of oncology dogma. Is it possible that medicine has misunderstood cancer treatment for decades? Dr. Soon-Shiong’s insights demand reflection. By protecting and activating lymphocytes, we might unlock the body’s true potential to heal.
4:13

Dr. Patrick Soon-Shiong challenges the core of cancer treatment: Are we fighting cancer incorrectly? In a compelling interview, he explains how lymphocytes—Natural Killer cells and T-cells—are the body’s critical defenders, essential for defeating cancer, infections, and sepsis. Yet, modern medicine has been undermining them. Lymphocytes are the body’s elite immune cells. Natural Killer cells and T-cells are uniquely equipped to destroy cancer cells and are vital for combating life-threatening infections and sepsis. Dr. Soon-Shiong describes them as the foundation for long life and survival. But there’s a problem. Conventional cancer treatments—chemotherapy, radiation, and steroids—destroy these lymphocytes, causing lymphopenia, a depletion akin to anemia but for the immune system. For decades, medicine has inadvertently targeted the very cells needed to win the war against cancer. A breakthrough molecule, IL-15, changes everything. This protein, produced naturally in the body, acts as a master switch to activate and proliferate lymphocytes, enabling them to eradicate cancer and infections. For the first time, medicine can harness this mechanism through BioShield. BioShield leverages IL-15 to empower lymphocytes, marking a revolutionary shift in treatment. Unlike chemotherapy, which Dr. Soon-Shiong likens to a nuclear bomb that devastates the body, IL-15 strengthens the immune system to fight smarter. Why have traditional treatments fallen short? Chemotherapy and radiation may shrink tumors, achieving what’s called a response, but at a steep cost. They deplete lymphocytes, weaken immunity, and allow resistant cancer cells to hide and later return as metastases. Dr. Soon-Shiong raises a provocative question: Have treatments induced incurability? The focus on response rates and progression-free survival, standard metrics for drug approval, misses the true goal: overall survival with high quality of life. Current therapies, often dosed at the maximum tolerated level, prioritize short-term wins over long-term health. Dr. Soon-Shiong critiques this approach, suggesting that medicine has been winning battles but losing wars. By destroying lymphocytes, treatments may shrink tumors temporarily but leave patients vulnerable to relapse. The regulatory system, he argues, has incentivized flawed endpoints. BioShield’s IL-15 therapy offers hope, activating the body’s natural defenses without obliterating them. This could redefine cancer care, prioritizing immune strength and long-term survival over transient tumor shrinkage. Dr. Soon-Shiong’s vision challenges 50 years of oncology dogma. Is it possible that medicine has misunderstood cancer treatment for decades? Dr. Soon-Shiong’s insights demand reflection. By protecting and activating lymphocytes, we might unlock the body’s true potential to heal.

Camus

45,915 просмотров • 1 год назад

A startling connection between COVID-19 and the surge in colon cancer is emerging. According to Dr. Patrick Soon-Shiong, new research from UCSF shows the virus can persist in the colon for years post-infection, severely depleting the natural killer cells that protect us. This immune suppression may be a key factor behind the rising global incidence. In response, Dr. Soon-Shiong announces the near-full recruitment of a groundbreaking US trial using BioShield to prevent colon cancer in high-risk Lynch syndrome patients. A critical step forward.
0:51

A startling connection between COVID-19 and the surge in colon cancer is emerging. According to Dr. Patrick Soon-Shiong, new research from UCSF shows the virus can persist in the colon for years post-infection, severely depleting the natural killer cells that protect us. This immune suppression may be a key factor behind the rising global incidence. In response, Dr. Soon-Shiong announces the near-full recruitment of a groundbreaking US trial using BioShield to prevent colon cancer in high-risk Lynch syndrome patients. A critical step forward.

Camus

30,726 просмотров • 10 месяцев назад

Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): It’s fully approved in the US for one rare form of bladder cancer… but not for the common form most patients have. So even though the same drug is already FDA-approved and sitting in their files, he can’t use it off-label for other patients without insane one-patient-at-a-time paperwork, IRB delays, and individual FDA sign-off. Meanwhile, Saudi Arabia (with their own sophisticated FDA) reviewed the exact same 1.7 million pages of data and approved it for more cancers. His blunt takeaway: Cancer is a war against time. Patients are forced to fly to Saudi Arabia for access… or wait in bureaucratic limbo while the clock runs out. “I’m completely befuddled as to why this molecule… that stimulates your NK cells is not allowed to give to people who have low NK cells.” If a drug is already FDA-approved and sitting in their own files, why the insane barriers to using it for other patients who are dying? Is this protecting people… or protecting something else?
2:42

Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): It’s fully approved in the US for one rare form of bladder cancer… but not for the common form most patients have. So even though the same drug is already FDA-approved and sitting in their files, he can’t use it off-label for other patients without insane one-patient-at-a-time paperwork, IRB delays, and individual FDA sign-off. Meanwhile, Saudi Arabia (with their own sophisticated FDA) reviewed the exact same 1.7 million pages of data and approved it for more cancers. His blunt takeaway: Cancer is a war against time. Patients are forced to fly to Saudi Arabia for access… or wait in bureaucratic limbo while the clock runs out. “I’m completely befuddled as to why this molecule… that stimulates your NK cells is not allowed to give to people who have low NK cells.” If a drug is already FDA-approved and sitting in their own files, why the insane barriers to using it for other patients who are dying? Is this protecting people… or protecting something else?

Camus

51,126 просмотров • 5 месяцев назад